Fenofibrate suppresses microvascular inflammation and apoptosis through adenosine monophosphate–activated protein kinase activation
- 30 April 2011
- journal article
- Published by Elsevier in Metabolism
- Vol. 60 (4), 513-522
- https://doi.org/10.1016/j.metabol.2010.04.020
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemiaCurrent Opinion in Cardiology, 2009
- Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trialThe Lancet, 2009
- When Metabolism Rules PerfusionCirculation Research, 2009
- Metformin Inhibits Cytokine-Induced Nuclear Factor κB Activation Via AMP-Activated Protein Kinase Activation in Vascular Endothelial CellsHypertension, 2006
- Fenofibrate activates AMPK and increases eNOS phosphorylation in HUVECBiochemical and Biophysical Research Communications, 2006
- 5-Aminoimidazole-4-Carboxamide-1-β-4-Ribofuranoside Inhibits Proinflammatory Response in Glial Cells: A Possible Role of AMP-Activated Protein KinaseJournal of Neuroscience, 2004
- Advanced Glycation End Product-induced Apoptosis and Overexpression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein-1 in Human-cultured Mesangial CellsJournal of Biological Chemistry, 2002
- Hydrogen peroxide activates IκB kinases through phosphorylation of serine residues in the activation loopsFEBS Letters, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001